Please assess the completion status of the following clinical trial:

Trial Title: Procedures for Sample Acquisition and Distribution for The Human Brain Collection Core

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
* INCLUSION CRITERIA:~Brain tissue is needed from individuals suffering from a variety of neuropsychiatric disorders, including schizophrenia, anxiety disorders, suicide, bipolar disorder, depression, and substance use disorders (cocaine, alcohol, heroin or the like). In addition, brains from individuals without a history of neuropsychiatric disease will be needed as controls.~EXCLUSION CRITERIA:~An assessment is carried out on the information available from the referral source (generally a Medical Examiner s Office) prior to obtaining consent. This information is usually very succinct, indicating how the decedent was found and, if known, whether they had some psychiatric or obvious medical history. The following cases will be~excluded from collection:~* Severe mental retardation.~* Well documented, long lasting seizure disorder.~* Infections known to affect the brain such as syphilis, tuberculosis, with the exception of HIV infection.~* The body is decomposed. We consider collecting the brain up to three days after death.~* There is obvious damage to the brain by closed head injury or other trauma (gunshot wound, fall, etc.).~* There are brain infarcts, hemorrhages, tumors, stroke, or other brain lesions that destroy the normal brain structure.~* The patient has been maintained on a respirator (ventilator) for more than 12 hours in the period immediately prior to death.~* Major sepsis.~* Serious renal or hepatic disease.~* Multiple sclerosis (MS), Alzheimer s disease and other dementias and degenerative diseases.~* Known infection with Hepatitis C

- Gender: ALL
- Minimum Age: None
- Maximum Age: 120 Years
- Healthy Volunteers: f

Study Arms:
- psychiatric disorders (Type: None): decedents with and without psychiatric use disorders
- substance disorders (Type: None): decedents with and without substance use disorders

Based on this trial design, predict the completion outcome and termination type (if applicable).